UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 165

Sortiert nach

HER2 Testing in Endometrial Serous Carcinoma: Time for Standardized Pathology Practice to Meet the Clinical Demand

Archives of pathology & laboratory medicine (1976), 2021-06, Vol.145 (6), p.687-691

Buza, Natalia

2021

Volltextzugriff (PDF)

Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine

Modern pathology, 2021-09, Vol.34 (9), p.1658-1672

2021

Volltextzugriff (PDF)

Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients

Modern pathology, 2020-06, Vol.33 (6), p.1172-1181

2020

Volltextzugriff (PDF)

Precision genotyping diagnosis of lung tumors with trophoblastic morphology in young women

Modern pathology, 2019-09, Vol.32 (9), p.1271-1280

2019

Volltextzugriff (PDF)

Hydatidiform Moles: Genetic Basis and Precision Diagnosis

Annual review of pathology, 2017-01, Vol.12, p.449

2017

Volltextzugriff (PDF)

HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy

Modern pathology, 2020-01, Vol.33 (1), p.118-127

2020

Volltextzugriff (PDF)

Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation

Modern pathology, 2019-05, Vol.32 (5), p.650-658

2019

Volltextzugriff (PDF)

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

Gynecologic oncology, 2020-04, Vol.157 (1), p.161-166

2020

Volltextzugriff (PDF)

Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement

Clinical cancer research, 2018-07, Vol.24 (14), p.3282-3291

2018

Volltextzugriff (PDF)

Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice

Modern pathology, 2013-12, Vol.26 (12), p.1605-1612

2013

Volltextzugriff (PDF)

Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study

Modern pathology, 2021-06, Vol.34 (6), p.1194-1202

2021

Volltextzugriff (PDF)

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition

Proceedings of the National Academy of Sciences - PNAS, 2016-10, Vol.113 (43), p.12238-12243

2016

Volltextzugriff (PDF)

Integrated mutational landscape analysis of uterine leiomyosarcomas

Proceedings of the National Academy of Sciences - PNAS, 2021-04, Vol.118 (15), p.e2025182118

2021

Volltextzugriff (PDF)

Paternal uniparental isodisomy of tyrosine hydroxylase locus at chromosome 11p15.4: spectrum of phenotypical presentations simulating hydatidiform moles

Modern pathology, 2019-08, Vol.32 (8), p.1180-1188

2019

Volltextzugriff (PDF)

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

Proceedings of the National Academy of Sciences - PNAS, 2013-02, Vol.110 (8), p.2916-2921

2013

Volltextzugriff (PDF)

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Proceedings of the National Academy of Sciences - PNAS, 2019-11, Vol.116 (45), p.22730-22736

2019

Volltextzugriff (PDF)

Lack of genetic homozygosity in prepubertal teratomas: divergent pathogenesis distinct from that of teratomas in adolescents

Laboratory investigation, 2020-11, Vol.100 (11), p.1447-1454

2020

Volltextzugriff (PDF)

Frozen Section Diagnosis of Ovarian Epithelial Tumors: Diagnostic Pearls and Pitfalls

Archives of pathology & laboratory medicine (1976), 2019-01, Vol.143 (1), p.47-64

Buza, Natalia

2019

Volltextzugriff (PDF)

Frequent homozygosity in both mature and immature ovarian teratomas: a shared genetic basis of tumorigenesis

Modern pathology, 2017-10, Vol.30 (10), p.1467-1475

2017

Volltextzugriff (PDF)

SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression

Clinical cancer research, 2017-10, Vol.23 (19), p.5836-5845

2017

Volltextzugriff (PDF)

Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors

Seminars in diagnostic pathology, 2022-01, Vol.39 (1), p.58-77

Buza, Natalia

2022

Volltextzugriff (PDF)

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

Molecular cancer therapeutics, 2018-05, Vol.17 (5), p.1003-1011

2018

Volltextzugriff (PDF)

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2019-01, Vol.116 (2), p.619-624

2019

Volltextzugriff (PDF)

Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study

Human pathology, 2014-09, Vol.45 (9), p.1885-1892

2014

Volltextzugriff (PDF)

Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease

Modern pathology, 2020-10, Vol.33 (10), p.1979-1988

2020

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(146)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

HER2 Testing in Endometrial Serous Carcinoma: Time for Standardized Pathology Practice to Meet the Clinical Demand

Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine

Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients

Precision genotyping diagnosis of lung tumors with trophoblastic morphology in young women

Hydatidiform Moles: Genetic Basis and Precision Diagnosis

HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy

Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement

Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice

Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition

Integrated mutational landscape analysis of uterine leiomyosarcomas

Paternal uniparental isodisomy of tyrosine hydroxylase locus at chromosome 11p15.4: spectrum of phenotypical presentations simulating hydatidiform moles

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Lack of genetic homozygosity in prepubertal teratomas: divergent pathogenesis distinct from that of teratomas in adolescents

Frozen Section Diagnosis of Ovarian Epithelial Tumors: Diagnostic Pearls and Pitfalls

Frequent homozygosity in both mature and immature ovarian teratomas: a shared genetic basis of tumorigenesis

SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression

Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors

In Vitro and In Vivo Activity of IMGN853, an Antibody-Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study

Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease

Suchergebnisse filtern